Early Warning (inbunden)
Inbunden (Hardback)
Antal sidor
Indiana University Press
4 figures
4 figures
243 x 163 x 22 mm
504 g
Antal komponenter
viii, 188 p. ;
Early Warning (inbunden)

Early Warning

Cases and Ethical Guidance for Presymptomatic Testing in Genetic Diseases

Inbunden Engelska, 1998-11-01
  • Skickas inom 7-10 vardagar.
  • Gratis frakt inom Sverige över 159 kr för privatpersoner.
Kan levereras innan julafton!
"This timely, well-written book brings together the collective experience of experts from the fields of medicine, psychiatry, religious studies, bioethics, and molecular genetics in an effort to develop coherent guidelines for the counseling of potential sufferers from genetic diseases." -Journal of Religion and Health This book presents 29 case studies that identify the most important ethical issues that are likely to emerge from new technologies of genetic testing and develops a series of guidelines based on those case studies. By providing the clinical origins and rationale behind each of its recommendations, the book will help readers think through the ethical issues and will assist them in the development of additional guidelines.
Visa hela texten

Passar bra ihop

  1. Early Warning
  2. +
  3. Health Care Finance

De som köpt den här boken har ofta också köpt Health Care Finance av Judith J Baker, R W Baker, Neil R Dworkin (inbunden).

Köp båda 2 för 1128 kr


Har du läst boken? Sätt ditt betyg »

Övrig information

Roger B. Dworkin is the Robert H. McKinney Professor of Law at Indiana University School of Law-Bloomington and Nelson Poynter Scholar and Director of Medical Studies at Indiana University's Poynter Center for the Study of Ethics and American Institutions. Dworkin, who has previously served as Professor of Biomedical History at the University of Washington School of Medicine, is an expert on the relationship between law and the biomedical sciences. He is the author of Limits: The Role of the Law in Bioethical Decision Making, and numerous articles in the field as well as the co-author of a leading casebook on law and medicine. Gregory P. Gramelspacher, M.D. is the founder and Director of the Program in Medical Ethics, Indiana University School of Medicine. He is a general internist with research interests in the areas of death and dying, advance directives, and ethical implications of the human genome project. Judith A. Granbois joined the staff of The Poynter Center for the Study of Ethics and American Institutions in 1980. She has taught writing and ethics courses at Indiana University and is the co-author of articles on various topics in biomedical ethics. Dr. Kimberly A. Quaid is Co-Director, Clinical Associate Professor of Medical Genetics and Psychiatry and Clinical Associate Professor of Medical and Molecular Genetics and Psychiatry at the Indiana University School of Medicine. Dr. Quaid coordinated one of the first programs in the country to offer predictive testing for Huntington disease at Johns Hopkins Hospital. She works with families at risk for Huntington disease, Gerstmann-Straussler-Scheinker disease and Alzheimer disease both in providing education and testing to patients and their families as well as doing research on the clinical outcomes of testing and is internationally recognized for her work in the development of ethically sound protocols for genetic testing. She has published numerous journal articles and is author of "Implications of susceptibility testing with Apolipoprotein E," in Stephen G. Post (ed.) Ethics, Genetics and Alzheimer Disease. David H. Smith is Professor of Religious Studies at Indiana University and Director of The Poynter Center for the Study of Ethics and American Institutions. He is a founding member of the Hospice of Bloomington and the Association for Practical and Professional Ethics. His publications include Entrusted: The Moral Responsibilities of Trusteeship and Health and Medicine in the Anglican Tradition: Conscience, Community, and Compromise. Dr. Gail Vance is an Assistant Professor in the Department of Medical and Molecular Genetics. Dr. Vance joined the Indiana University School of Medicine faculty in 1992, after completing fellowships in clinical genetics and cytogenetics. Dr. Vance is board certified in Pediatrics (American Board of Pediatrics, l990), Clinical Pathology (American Board of Pathology, l989), and Medical Genetics and Clinical Cytogenetics (American Board of Genetics, 1993). Dr. Vance developed the Indiana Familial Cancer Program in the Department of Medical and Molecular Genetics in l993, to provide genetic counseling and genetic testing to individuals with a high risk for the development of cancer. She is also Assistant Director of the Cytogenetic laboratory.


Introduction Cases Case 1 - Paul and Michael Case 2 - Father and Son Case 3 - Sarah Case 4 - Ann and Jack Case 5 - Carol Case 6 - Kirsten and David Case 7 - Robert Case 8 - Mr. H Case 9 - Natalie Case 10 - Mary Ann Case 11 - Maurice Case 12 - Mr. L Case 13 - Mr. Crawford Case 14 - Mr. and Mrs. Anderson Case 15 - Jimmy Case 16 - Harriet Case 17 - Charley Case 18 - Mr. and Mrs. B Case 19 - Julie Case 20 - Barbara Case 21 - Doug Case 22 - Uncle Lee Case 23 - Emily Case 24 - Mrs. K Case 25 - Ruth Case 26 - Jackie Case 27 - Aunt Mary Case 28 - Scott Case 29 - Mrs. Sawyer Guidelines and Commentary Guideline I Guideline II Guideline III Guideline IV Guideline V Guideline VI Guideline VII Guideline VIII Guideline IX Guideline X Guideline XI Glossary References